These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33947152)

  • 1. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
    Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer.
    Koutsioumpa M; Chen HW; O'Brien N; Koinis F; Mahurkar-Joshi S; Vorvis C; Soroosh A; Luo T; Issakhanian S; Pantuck AJ; Georgoulias V; Iliopoulos D; Slamon DJ; Drakaki A
    Mol Cancer Ther; 2018 Jul; 17(7):1430-1440. PubMed ID: 29703843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
    Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
    Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
    Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G
    Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.
    Di Martino MT; Gullà A; Gallo Cantafio ME; Altomare E; Amodio N; Leone E; Morelli E; Lio SG; Caracciolo D; Rossi M; Frandsen NM; Tagliaferri P; Tassone P
    PLoS One; 2014; 9(2):e89659. PubMed ID: 24586944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer.
    Zhang L; Xu J; Yang G; Li H; Guo X
    Oncol Res; 2018 Jul; 26(6):949-957. PubMed ID: 29298735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
    Wang J; Zhao X; Shi J; Pan Y; Chen Q; Leng P; Wang Y
    Oncol Rep; 2016 Oct; 36(4):2049-58. PubMed ID: 27571748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
    Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
    Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
    Murphy BL; Obad S; Bihannic L; Ayrault O; Zindy F; Kauppinen S; Roussel MF
    Cancer Res; 2013 Dec; 73(23):7068-78. PubMed ID: 24145352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy.
    Li H; Yu G; Shi R; Lang B; Chen X; Xia D; Xiao H; Guo X; Guan W; Ye Z; Xiao W; Xu H
    Mol Cancer; 2014 Jan; 13():8. PubMed ID: 24423412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p.
    Li Z; Hu C; Zhen Y; Pang B; Yi H; Chen X
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression.
    Cui X; Kong C; Zhu Y; Zeng Y; Zhang Z; Liu X; Zhan B; Piao C; Jiang Z
    Oncotarget; 2016 Jul; 7(30):48547-48561. PubMed ID: 27391066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.
    Matalkah F; Martin E; Zhao H; Agazie YM
    Breast Cancer Res; 2016 Jan; 18(1):2. PubMed ID: 26728598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
    Zhang L; Wang CZ; Ma M; Shao GF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
    Liu X; Kong C; Zhang Z
    Oncol Rep; 2018 May; 39(5):2324-2332. PubMed ID: 29512748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
    Yang J; Yuan D; Li J; Zheng S; Wang B
    Tumour Biol; 2016 Apr; 37(4):4331-41. PubMed ID: 26494000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.